ZNF214
geneOn this page
Summary
ZNF214 (zinc finger protein 214, HGNC:13006) is a protein-coding gene on chromosome 11p15.4, encoding Zinc finger protein 214 (Q9UL59). May be involved in transcriptional regulation.
This gene is expressed predominantly in the testis and encodes a zinc finger protein that contains an N-terminal kruppel-associated box A (KRABA) domain and twelve zinc finger domains. This gene is located within one of three regions on chromosome 11p15 associated with Beckwith-Wiedemann syndrome, called Beckwith-Wiedemann syndrome chromosome region-2 (BWSCR2), and is thought to play a role in the etiology of this disease.
Source: NCBI Gene 7761 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 98 total
- MANE Select transcript:
NM_013249
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13006 |
| Approved symbol | ZNF214 |
| Name | zinc finger protein 214 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000149050 |
| Ensembl biotype | protein_coding |
| OMIM | 605015 |
| Entrez | 7761 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000278314, ENST00000525017, ENST00000531083, ENST00000536068, ENST00000888786, ENST00000888787, ENST00000888788, ENST00000888789
RefSeq mRNA: 5 — MANE Select: NM_013249
NM_001354830, NM_001354831, NM_001354832, NM_001354833, NM_013249
CCDS: CCDS31418
Canonical transcript exons
ENST00000278314 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000988626 | 7002709 | 7002855 |
| ENSE00000988627 | 6997085 | 7001555 |
| ENSE00002188459 | 7020073 | 7020346 |
Expression profiles
Bgee: expression breadth ubiquitous, 174 present calls, max score 87.16.
FANTOM5 (CAGE): breadth broad, TPM avg 1.7804 / max 91.0908, expressed in 796 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 118462 | 1.7804 | 796 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 87.16 | gold quality |
| oocyte | CL:0000023 | 80.72 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.13 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.43 | gold quality |
| ventricular zone | UBERON:0003053 | 79.13 | gold quality |
| right uterine tube | UBERON:0001302 | 79.00 | gold quality |
| tendon | UBERON:0000043 | 76.72 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.05 | gold quality |
| secondary oocyte | CL:0000655 | 75.78 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.98 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 73.73 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.56 | gold quality |
| superficial temporal artery | UBERON:0001614 | 72.33 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 72.18 | gold quality |
| cortical plate | UBERON:0005343 | 71.39 | gold quality |
| left ovary | UBERON:0002119 | 71.15 | gold quality |
| body of uterus | UBERON:0009853 | 71.11 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.71 | gold quality |
| right ovary | UBERON:0002118 | 70.42 | gold quality |
| endocervix | UBERON:0000458 | 69.92 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 69.54 | gold quality |
| mucosa of stomach | UBERON:0001199 | 69.30 | gold quality |
| bronchial epithelial cell | CL:0002328 | 69.27 | gold quality |
| ovary | UBERON:0000992 | 69.04 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 68.42 | gold quality |
| ectocervix | UBERON:0012249 | 68.31 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 68.17 | gold quality |
| thyroid gland | UBERON:0002046 | 67.75 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 67.20 | gold quality |
| rectum | UBERON:0001052 | 66.96 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.28 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1975.1 | ZNF214 | More than 3 adjacent zinc fingers |
| MA1975.2 | ZNF214 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28273063
Literature-anchored findings (GeneRIF, showing 1)
- For a number of genes affected by de novo copy number variants CNVs in autism (CNTNAP2, ZNF214, ARID1B, Proline Dehydrogenase), reduced transcript expression may be a mechanism of pathogenesis during neurodevelopment. (PMID:21448237)
Cross-species orthologs
0 orthologs
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein 214 — Q9UL59 (reviewed: Q9UL59)
Alternative names: BWSCR2-associated zinc finger protein 1
All UniProt accessions (1): Q9UL59
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (5): NP_001341759, NP_001341760, NP_001341761, NP_001341762, NP_037381* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050636 | C2H2-ZF_domain-containing | Family |
Pfam: PF00096, PF01352
UniProt features (18 total): zinc finger region 11, sequence variant 4, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UL59-F1 | 62.28 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 40 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, MODULE_48, MODULE_95, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MODULE_49, MODULE_163, ATM_DN.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF8_TARGET_GENES, MIR1277_5P, MIR3619_5P, MIR12135, MIR214_3P, MIR761, MIR6715A_3P
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
390 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF214 | BAZ2B | Q9UIF8 | 803 |
| ZNF214 | BAZ2A | Q9UIF9 | 798 |
| ZNF214 | BAZ1A | Q9NRL2 | 677 |
| ZNF214 | BAZ1B | Q9UIG0 | 653 |
| ZNF214 | NAP1L4 | Q99733 | 588 |
| ZNF214 | DYNC1I2 | Q13409 | 542 |
| ZNF214 | NSD1 | Q96L73 | 497 |
| ZNF214 | IGF2 | P01344 | 496 |
| ZNF214 | OR2W3 | Q7Z3T1 | 494 |
| ZNF214 | TGM1 | P22735 | 440 |
| ZNF214 | DLK1 | P15803 | 423 |
| ZNF214 | OR2D3 | Q8NGH3 | 421 |
| ZNF214 | COG6 | Q9Y2V7 | 421 |
| ZNF214 | ZNF215 | Q9UL58 | 408 |
| ZNF214 | OR10A3 | P58181 | 385 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF214 | LRP4 | psi-mi:“MI:0914”(association) | 0.530 |
| RBM11 | ZNF214 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (23): USP34 (Affinity Capture-MS), ANKS3 (Affinity Capture-MS), TOPORS (Affinity Capture-MS), SOGA3 (Affinity Capture-MS), CENPB (Affinity Capture-MS), SMARCAD1 (Affinity Capture-MS), NEK7 (Affinity Capture-MS), TRIM37 (Affinity Capture-MS), LRP4 (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), ZC3H18 (Affinity Capture-MS), CBX6 (Affinity Capture-MS), ZNF214 (Synthetic Lethality), USP34 (Affinity Capture-MS), CBX6 (Affinity Capture-MS)
ESM2 similar proteins: A0JPL0, A6NK53, E7ETH6, E9Q8G5, O14628, P21506, P51508, Q09FC8, Q13360, Q2M218, Q2M3X9, Q2VY69, Q3KQV3, Q3SY52, Q4R882, Q5HY98, Q5REN4, Q5RES8, Q68DI1, Q6NX49, Q6P280, Q6PG37, Q6V9R5, Q6ZMW2, Q7Z340, Q86XU0, Q8IYI8, Q8N587, Q8N720, Q8N859, Q8NB42, Q8NDW4, Q8NEK5, Q8WXB4, Q96MR9, Q96MU6, Q96NG8, Q96NJ3, Q96SR6, Q9BR84
Diamond homologs: A0JPL0, A8MT65, A8MUZ8, A8MWA4, B2RXC5, B4DU55, B7Z6K7, C9JN71, E9Q8G5, O75820, P0CH99, P0CI00, P0DPD5, P10076, P10755, P17017, P17024, P17031, P17039, P51508, P52737, Q02525, Q02975, Q06730, Q06732, Q08AG5, Q0VCB0, Q13106, Q13398, Q147U1, Q15973, Q2M3X9, Q4R4C7, Q4R882, Q4R8H9, Q5JUW0, Q5MCW4, Q5R4K8, Q5R9F0, Q5RB33
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
98 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 75 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
797 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:7002708:CCTA:C | donor_gain | 1.0000 |
| 11:7002711:A:AC | donor_gain | 1.0000 |
| 11:7002712:C:CC | donor_gain | 1.0000 |
| 11:7002712:CTGA:C | donor_gain | 1.0000 |
| 11:7002747:T:TA | donor_gain | 1.0000 |
| 11:7002748:C:A | donor_gain | 1.0000 |
| 11:7001552:TTTTC:T | acceptor_loss | 0.9900 |
| 11:7001553:TTTCT:T | acceptor_loss | 0.9900 |
| 11:7001554:TTCT:T | acceptor_loss | 0.9900 |
| 11:7001555:TCTA:T | acceptor_loss | 0.9900 |
| 11:7001556:C:CC | acceptor_gain | 0.9900 |
| 11:7001556:C:T | acceptor_loss | 0.9900 |
| 11:7001557:T:A | acceptor_loss | 0.9900 |
| 11:7002852:CTTT:C | acceptor_gain | 0.9900 |
| 11:7002856:C:CC | acceptor_gain | 0.9900 |
| 11:7020088:A:C | donor_gain | 0.9900 |
| 11:7020116:T:C | donor_gain | 0.9900 |
| 11:7020190:T:TA | donor_gain | 0.9900 |
| 11:7001551:GTTTT:G | acceptor_gain | 0.9800 |
| 11:7001552:TTTT:T | acceptor_gain | 0.9800 |
| 11:7001553:TTT:T | acceptor_gain | 0.9800 |
| 11:7001554:TT:T | acceptor_gain | 0.9800 |
| 11:7002741:A:AC | donor_gain | 0.9800 |
| 11:7002742:TG:T | donor_gain | 0.9800 |
| 11:7002854:TT:T | acceptor_gain | 0.9800 |
| 11:7002715:A:AC | donor_gain | 0.9700 |
| 11:7002716:C:CC | donor_gain | 0.9700 |
| 11:7002716:CATGA:C | donor_gain | 0.9700 |
| 11:7002853:TTT:T | acceptor_gain | 0.9700 |
| 11:7002743:G:T | donor_gain | 0.9600 |
AlphaMissense
4073 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:6999994:G:C | F563L | 0.999 |
| 11:6999994:G:T | F563L | 0.999 |
| 11:6999996:A:G | F563L | 0.999 |
| 11:7000078:A:C | F535L | 0.999 |
| 11:7000078:A:T | F535L | 0.999 |
| 11:7000080:A:G | F535L | 0.999 |
| 11:7000162:G:C | F507L | 0.999 |
| 11:7000162:G:T | F507L | 0.999 |
| 11:7000164:A:G | F507L | 0.999 |
| 11:7000246:G:C | F479L | 0.999 |
| 11:7000246:G:T | F479L | 0.999 |
| 11:7000248:A:G | F479L | 0.999 |
| 11:7000330:A:C | F451L | 0.999 |
| 11:7000330:A:T | F451L | 0.999 |
| 11:7000332:A:G | F451L | 0.999 |
| 11:7000414:A:C | F423L | 0.999 |
| 11:7000414:A:T | F423L | 0.999 |
| 11:7000416:A:G | F423L | 0.999 |
| 11:7000498:G:C | F395L | 0.999 |
| 11:7000498:G:T | F395L | 0.999 |
| 11:7000500:A:G | F395L | 0.999 |
| 11:7000481:A:G | L401P | 0.998 |
| 11:7000079:A:G | F535S | 0.997 |
| 11:7000145:A:G | L513P | 0.997 |
| 11:7000163:A:G | F507S | 0.997 |
| 11:7000229:A:G | L485P | 0.997 |
| 11:7000313:A:G | L457P | 0.997 |
| 11:7000397:A:G | L429P | 0.997 |
| 11:7000415:A:G | F423S | 0.997 |
| 11:7000499:A:G | F395S | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000107318 (11:6998252 G>A), RS1000174724 (11:7001550 A>G), RS1000204526 (11:7005153 C>A), RS1000480590 (11:7017994 T>G), RS1000521678 (11:6997955 G>T), RS1000537133 (11:7017891 T>C), RS1000741456 (11:7018268 C>A), RS1000839547 (11:6998426 G>A), RS1000937859 (11:7004709 G>A), RS1001149594 (11:7011705 A>C,G), RS1001498007 (11:7011131 T>C), RS1001522499 (11:7011574 A>C), RS1001704257 (11:7017397 C>T), RS1001715690 (11:7004760 T>C), RS1001836387 (11:7012761 C>T)
Disease associations
OMIM: gene MIM:605015 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, decreases methylation | 4 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | increases expression, decreases expression | 1 |
| propionaldehyde | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression, affects cotreatment | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Aldehydes | decreases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Lead | decreases expression | 1 |
| Melphalan | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Vanadates | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW20 | HEK293 eGFP-ZNF214 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): malaria